Home/Filings/4/0000899243-22-002195
4//SEC Filing

Karunatilake Chulani 4

Accession 0000899243-22-002195

CIK 0001785530other

Filed

Jan 17, 7:00 PM ET

Accepted

Jan 18, 6:29 PM ET

Size

5.6 KB

Accession

0000899243-22-002195

Insider Transaction Report

Form 4
Period: 2022-01-06
Karunatilake Chulani
Chief Technology Officer
Transactions
  • Award

    Stock Option (right to buy)

    2022-01-06+34,25834,258 total
    Exercise: $11.55Exp: 2032-01-05Common Stock (34,258 underlying)
Footnotes (1)
  • [F1]The option was granted on January 6, 2022 with a Vesting Commencement Date of January 1, 2022. The shares underlying the option vest over four years, with 25% of the shares vesting on the first anniversary of the Vesting Commencement Date and 2.0833% of the shares vesting each month thereafter through January 1, 2026.

Issuer

Werewolf Therapeutics, Inc.

CIK 0001785530

Entity typeother

Related Parties

1
  • filerCIK 0001867326

Filing Metadata

Form type
4
Filed
Jan 17, 7:00 PM ET
Accepted
Jan 18, 6:29 PM ET
Size
5.6 KB